Delivery Order SPE2DB25D3003-SPE2DB25FPWZP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.18 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $15,612.00 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This competitively awarded, firm fixed-price contract includes performance at AmerisourceBergen's Conshohocken, Pennsylvania facility with an ultimate completion date of August 1, 2025. The delivery order carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This $2,621.00 firm fixed-price delivery order, with performance in Park Ridge, Illinois, represents a non-competitive award under an existing contract vehicle. The delivery is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Premarin 0.625 mg tablets in quantities of 100, with a contract ceiling value of $3,141.71. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, with a ceiling value of $1,417.13 and an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWZPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $44,883.40 firm fixed-price delivery order on August 20, 2025, for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of August 21, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply brand-name and generic medications, vaccines, and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.9k | 8/20/25 |